← Back to Search

Mindfulness for Alcoholism (MIT Trial)

N/A

Recruiting

Research Sponsored by The Mind Research Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18-65 years of age

Female (biological sex at birth)

Must not have

Major medical illness or Central Nervous System disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up an average of six months after release from incarceration

Awards & highlights

No Placebo-Only Group

Summary

This trial will support the development and evaluation of a mindfulness intervention for female prison inmates that will target key neuropsychological vulnerabilities that are associated with relapse and recidivism.

Who is the study for?

This trial is for English-speaking female inmates aged 18-65 with alcohol use disorder, who are not due to be released within the next three months. They must have at least a 5th-grade reading level. Those with metal in their body, low IQ scores, psychotic disorders, dementia or cognitive disabilities, major illnesses or CNS diseases, and severe hearing or vision problems cannot join.

What is being tested?

The study is evaluating a mindfulness program designed to address neuropsychological factors linked to relapse and criminal behavior in women prisoners with alcohol abuse issues. The goal is to reduce the cycle of drinking and re-offending.

What are the potential side effects?

Mindfulness interventions typically do not cause physical side effects but can sometimes lead to increased emotional sensitivity or discomfort as participants become more aware of their thoughts and feelings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Select...

I am biologically female.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have a major illness or brain disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks, 8 weeks, and after release from incarceration (every 3 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks, 8 weeks, and after release from incarceration (every 3 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks, 8 weeks, and after release from incarceration (every 3 months) for reporting.